| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1311924
[patent_doc_number] => 06610542
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-26
[patent_title] => 'Efficient ex vivo expansion of cd4 and cd8 T-cells from HIV infected subjects'
[patent_app_type] => B1
[patent_app_number] => 09/296402
[patent_app_country] => US
[patent_app_date] => 1999-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11472
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610542.pdf
[firstpage_image] =>[orig_patent_app_number] => 09296402
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/296402 | Efficient ex vivo expansion of cd4 and cd8 T-cells from HIV infected subjects | Apr 22, 1999 | Issued |
Array
(
[id] => 5830715
[patent_doc_number] => 20020069422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'NEW POLYPEPTIDES AND PEPTIDES, NUCLEIC ACIDS CODING FOR THEM, AND THEIR USE IN THE FIELD OF TUMOR THERAPY, INFLAMMATION OR IMMUNOLOGY'
[patent_app_type] => new
[patent_app_number] => 09/294121
[patent_app_country] => US
[patent_app_date] => 1999-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 23654
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20020069422.pdf
[firstpage_image] =>[orig_patent_app_number] => 09294121
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/294121 | NEW POLYPEPTIDES AND PEPTIDES, NUCLEIC ACIDS CODING FOR THEM, AND THEIR USE IN THE FIELD OF TUMOR THERAPY, INFLAMMATION OR IMMUNOLOGY | Apr 18, 1999 | Abandoned |
Array
(
[id] => 1493984
[patent_doc_number] => 06342371
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-29
[patent_title] => 'Interleukin-1 homologue, IL-1H4'
[patent_app_type] => B1
[patent_app_number] => 09/293625
[patent_app_country] => US
[patent_app_date] => 1999-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9812
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/342/06342371.pdf
[firstpage_image] =>[orig_patent_app_number] => 09293625
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/293625 | Interleukin-1 homologue, IL-1H4 | Apr 15, 1999 | Issued |
Array
(
[id] => 4338538
[patent_doc_number] => 06284242
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Method for enhancing myoblast migration and invasion in the context of gene therapy'
[patent_app_type] => 1
[patent_app_number] => 9/293125
[patent_app_country] => US
[patent_app_date] => 1999-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13482
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284242.pdf
[firstpage_image] =>[orig_patent_app_number] => 293125
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/293125 | Method for enhancing myoblast migration and invasion in the context of gene therapy | Apr 15, 1999 | Issued |
| 09/230247 | DROSOPHILA MELANOGASTER P70 S6 KINASE | Apr 15, 1999 | Abandoned |
| 09/285516 | MURA | Apr 1, 1999 | Abandoned |
Array
(
[id] => 1290837
[patent_doc_number] => 06630346
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-07
[patent_title] => 'Gene therapy for obesity'
[patent_app_type] => B1
[patent_app_number] => 09/202684
[patent_app_country] => US
[patent_app_date] => 1999-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 53
[patent_no_of_words] => 11484
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/630/06630346.pdf
[firstpage_image] =>[orig_patent_app_number] => 09202684
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/202684 | Gene therapy for obesity | Mar 31, 1999 | Issued |
Array
(
[id] => 1126112
[patent_doc_number] => 06790637
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-14
[patent_title] => 'Mammalian gene, BCL-W, belongs to the BCL-2 family of apoptosis-controlling genes'
[patent_app_type] => B1
[patent_app_number] => 09/155327
[patent_app_country] => US
[patent_app_date] => 1999-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 29
[patent_no_of_words] => 15609
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/790/06790637.pdf
[firstpage_image] =>[orig_patent_app_number] => 09155327
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/155327 | Mammalian gene, BCL-W, belongs to the BCL-2 family of apoptosis-controlling genes | Mar 28, 1999 | Issued |
| 09/277398 | CLONING OF A NOVEL 7TM RECEPTOR AXOR-2 | Mar 25, 1999 | Abandoned |
| 09/276246 | Polynucleotides encoding the 3-hydroxy -3methylglutaryl-coenzyme A reductase of Streptococcus pneumoniae, mvaA | Mar 24, 1999 | Abandoned |
| 09/271839 | MURINE INTERFERON-ALPHA | Mar 17, 1999 | Abandoned |
| 09/262563 | POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES ENCODING HUMAN ORGANIC ANION TRANSPORTER 6 (HOATP6) AND SCREENING METHODS THEREOF | Mar 3, 1999 | Abandoned |
| 09/260771 | Q16 | Mar 1, 1999 | Abandoned |
| 09/260298 | AXOR14, A G-PROTEIN COUPLED RECEPTOR | Mar 1, 1999 | Abandoned |
| 09/257438 | TKTA | Feb 24, 1999 | Abandoned |
Array
(
[id] => 1037161
[patent_doc_number] => 06872387
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-29
[patent_title] => 'Three-dimensional hydrogel/cell system'
[patent_app_type] => utility
[patent_app_number] => 09/255963
[patent_app_country] => US
[patent_app_date] => 1999-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4950
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872387.pdf
[firstpage_image] =>[orig_patent_app_number] => 09255963
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/255963 | Three-dimensional hydrogel/cell system | Feb 22, 1999 | Issued |
Array
(
[id] => 1411160
[patent_doc_number] => 06528481
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-04
[patent_title] => 'NG2/HM proteoglycan-binding peptides that home to angiogenic vasculature and related methods'
[patent_app_type] => B1
[patent_app_number] => 09/250700
[patent_app_country] => US
[patent_app_date] => 1999-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 19540
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528481.pdf
[firstpage_image] =>[orig_patent_app_number] => 09250700
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/250700 | NG2/HM proteoglycan-binding peptides that home to angiogenic vasculature and related methods | Feb 15, 1999 | Issued |
Array
(
[id] => 1096941
[patent_doc_number] => 06822137
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-23
[patent_title] => 'Nucleotide sequence encoding the enzyme I-SCEI and the uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/244130
[patent_app_country] => US
[patent_app_date] => 1999-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 64
[patent_no_of_words] => 24498
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/822/06822137.pdf
[firstpage_image] =>[orig_patent_app_number] => 09244130
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/244130 | Nucleotide sequence encoding the enzyme I-SCEI and the uses thereof | Feb 3, 1999 | Issued |
Array
(
[id] => 4320940
[patent_doc_number] => 06331412
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Methods and compounds for modulating male fertility'
[patent_app_type] => 1
[patent_app_number] => 9/239867
[patent_app_country] => US
[patent_app_date] => 1999-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 16439
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331412.pdf
[firstpage_image] =>[orig_patent_app_number] => 239867
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/239867 | Methods and compounds for modulating male fertility | Jan 28, 1999 | Issued |
| 09/238478 | MVK | Jan 27, 1999 | Abandoned |